0185-0115 : Ticlopidine 250 mg Oral Tablet
| NDC: | 0185-0115 |
| Labeler: | Eon Labs, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Ticlopidine Hydrochloride |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | ANDA075326 |
| Rev. Date: |
Appearance:
| Markings: | E115 |
| Shapes: |
Oval |
| Colors: |
 White |
| Size (mm): | 15 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 0185-0115-05: 500 TABLET, FILM COATED IN 1 BOTTLE (0185‑0115‑05)
- 0185-0115-30: 30 TABLET, FILM COATED IN 1 BOTTLE (0185‑0115‑30)
- 0185-0115-60: 60 TABLET, FILM COATED IN 1 BOTTLE (0185‑0115‑60)
Active Ingredients:
- Ticlopidine Hydrochloride
Dosage Strength:
- 250 mg
Inactive Ingredients:
- Colloidal Silicon Dioxide
- Starch, Corn
- Hypromelloses
- Magnesium Stearate
- Cellulose, Microcrystalline
- Polyethylene Glycol
- Polysorbate 80
- Povidone
- Titanium Dioxide
Pharmaceutical Classes:
- Decreased Platelet Aggregation [PE]
- Platelet Aggregation Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 0093-0154 Ticlopidine 250 mg Oral Tablet by Teva Pharmaceuticals USA Inc
- 42291-803 Ticlopidine Hydrochloride 250 mg Oral Tablet by Avkare, Inc.
- 55567-054 Ticlopidine 250 mg Oral Tablet by Genpharm
- 57664-327 Ticlopidine 250 mg Oral Tablet by Caraco Pharmaceutical Laboratories, Ltd.
- 60505-0027 Ticlopidine 250 mg Oral Tablet by Apotex Corp.
- 68151-0079 Ticlopidine Hydrochloride 250 mg Oral Tablet, Film Coated by Carilion Materials Management
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0185-0111Next: 0185-0117 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.